ATL Technology acquires manufacturing operations of Gyrus Medical

并购
ATL Technology announced that it acquired manufacturing operations of Gyrus Medical from Olympus Surgical Technologies Europe. Cardiff, Wales-based Gyrus also offers device outsourcing. ATL said in a news release that it expects the acquisition to increase its global footprint and capabilities. ATL offers outsourced design, development and manufacturing services. The company focuses on providing engineering solutions to offer best-in-class medical device products. Olympus Surgical Technologies Europe serves as the European development and manufacturing center for medical technology within the Olympus Corporation. “This is a very strategic event for ATL,” said ATL Technology CEO Joe Glover. “We look forward to incorporating Gyrus’ capabilities into ATL’s existing offerings and to expand our global footprint deeper onto the European continent.” Glover added that the company is enthusiastic about adding the Gyrus team to its own. He believes Gyrus’ “significant engineering capabilities” can enhance the existing resources at ATL and allow it to continue growth. “Over the past 30 years, Gyrus, much like ATL, has worked with medical device original equipment manufacturer (OEM) customers to develop and manufacture innovative solutions to improve patient care,” said Simon Edwards, Gyrus Executive Managing Director. “We are looking forward to this strategic combination to continue and enhance this work for our OEM customers.”
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。